Publications by authors named "Tim D Bovee"

Claim this Profile
A
Auristatin S: An Auristatin Payload with Improved Tolerability and Modified Bystander Activity.
Philip N Moquist, Nicole M-L Eng-Duncan, Tim D Bovee, Katie Snead, Lauren Bou

ACS Med Chem Lett· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Auristatins with High Bystander and Cytotoxic Activities in Drug Efflux-positive Tumor Models.
Philip N Moquist, Tim D Bovee, Andrew B Waight, Jamie A Mitchell, Jamie B Miyamoto

Mol Cancer Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index.
Robert P Lyon, Tim D Bovee, Svetlana O Doronina, Patrick J Burke, Joshua H Hunter

Nat Biotechnol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates.
Robert P Lyon, Jocelyn R Setter, Tim D Bovee, Svetlana O Doronina, Joshua H Hunter

Nat Biotechnol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel peptide linkers for highly potent antibody-auristatin conjugate.
Svetlana O Doronina, Tim D Bovee, David W Meyer, Jamie B Miyamoto, Martha E Anderson

Bioconjug Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity.
Svetlana O Doronina, Brian A Mendelsohn, Tim D Bovee, Charles G Cerveny, Stephen C Alley

Bioconjug Chem· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of potent monoclonal antibody auristatin conjugates for cancer therapy.
Svetlana O Doronina, Brian E Toki, Michael Y Torgov, Brian A Mendelsohn, Charles G Cerveny, Tim D Bovee

Nat Biotechnol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis